-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Surrozen, Inc. (NASDAQ:SRZN) Short Interest Update
Surrozen, Inc. (NASDAQ:SRZN) Short Interest Update
Surrozen, Inc. (NASDAQ:SRZN – Get Rating) was the target of a significant growth in short interest in December. As of December 30th, there was short interest totalling 279,700 shares, a growth of 188.4% from the December 15th total of 97,000 shares. Currently, 1.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 678,900 shares, the days-to-cover ratio is currently 0.4 days.
Surrozen Stock Up 4.5 %
Shares of Surrozen stock opened at $0.65 on Wednesday. The stock has a market cap of $22.75 million, a PE ratio of -0.48 and a beta of -0.24. Surrozen has a 12 month low of $0.34 and a 12 month high of $4.82. The business has a fifty day simple moving average of $0.73 and a 200-day simple moving average of $1.98.
Get Surrozen alerts:Surrozen (NASDAQ:SRZN – Get Rating) last posted its quarterly earnings results on Monday, November 14th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.43) by $0.05. Analysts expect that Surrozen will post -1.46 EPS for the current fiscal year.
Hedge Funds Weigh In On Surrozen
Several institutional investors and hedge funds have recently modified their holdings of SRZN. Bank of Montreal Can purchased a new position in Surrozen in the first quarter valued at about $377,000. FMR LLC bought a new stake in shares of Surrozen in the 2nd quarter valued at approximately $744,000. Vanguard Group Inc. increased its holdings in Surrozen by 3.2% in the third quarter. Vanguard Group Inc. now owns 487,278 shares of the company's stock worth $984,000 after buying an additional 15,299 shares during the last quarter. Finally, Board of Trustees of The Leland Stanford Junior University lifted its stake in Surrozen by 3,102.9% in the third quarter. Board of Trustees of The Leland Stanford Junior University now owns 781,960 shares of the company's stock valued at $1,580,000 after acquiring an additional 757,546 shares during the last quarter. 62.13% of the stock is currently owned by hedge funds and other institutional investors.Analysts Set New Price Targets
Several equities analysts have recently issued reports on SRZN shares. Bank of America cut shares of Surrozen from a "neutral" rating to an "underperform" rating in a research note on Wednesday, November 16th. JPMorgan Chase & Co. downgraded Surrozen from a "neutral" rating to an "underweight" rating in a report on Tuesday, November 29th. Finally, Guggenheim downgraded Surrozen from a "buy" rating to a "neutral" rating in a report on Friday, November 18th.
Surrozen Company Profile
(Get Rating)
Surrozen, Inc, a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.
Featured Stories
- Get a free copy of the StockNews.com research report on Surrozen (SRZN)
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
- Does it Matter Folks Aren't "Starry-Eyed" Over Pepsi's New Soda?
- Can Alaska Air Continue Soaring Above The Airline Industry?
- Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
Receive News & Ratings for Surrozen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surrozen and related companies with MarketBeat.com's FREE daily email newsletter.
Surrozen, Inc. (NASDAQ:SRZN – Get Rating) was the target of a significant growth in short interest in December. As of December 30th, there was short interest totalling 279,700 shares, a growth of 188.4% from the December 15th total of 97,000 shares. Currently, 1.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 678,900 shares, the days-to-cover ratio is currently 0.4 days.
Surrozen, Inc.（纳斯达克股票代码：SRZN — Get Rating）是12月空头利率大幅增长的目标。截至12月30日，空头利率共计27.97万股，较12月15日的9.7万股总额增长了188.4％。目前，该股有1.5％的股票被卖空。根据678,900股的平均每日交易量，目前天数与覆盖率为0.4天。
Surrozen Stock Up 4.5 %
Surrozen 股票上涨了 4.5%
Shares of Surrozen stock opened at $0.65 on Wednesday. The stock has a market cap of $22.75 million, a PE ratio of -0.48 and a beta of -0.24. Surrozen has a 12 month low of $0.34 and a 12 month high of $4.82. The business has a fifty day simple moving average of $0.73 and a 200-day simple moving average of $1.98.
Surorizen股票周三开盘价为0.65美元。该股的市值为2,275万美元，市盈率为-0.48，beta值为-0.24。Surrozen创下12个月低点0.34美元，12个月高点为4.82美元。该公司的五十天简单移动平均线为0.73美元，200天简单移动平均线为1.98美元。
Surrozen (NASDAQ:SRZN – Get Rating) last posted its quarterly earnings results on Monday, November 14th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.43) by $0.05. Analysts expect that Surrozen will post -1.46 EPS for the current fiscal year.
Surrozen（纳斯达克股票代码：SRZN — Get Rating）最后一次公布季度财报是在11月14日星期一。该公司公布的本季度每股收益（EPS）（0.38美元），比分析师的共识预期（0.43美元）高出0.05美元。分析师预计，Surrozen将在本财年公布每股收益为-1.46。
Hedge Funds Weigh In On Surrozen
对冲基金对代理人施加压力
Analysts Set New Price Targets
分析师设定了新的价格目标
Several equities analysts have recently issued reports on SRZN shares. Bank of America cut shares of Surrozen from a "neutral" rating to an "underperform" rating in a research note on Wednesday, November 16th. JPMorgan Chase & Co. downgraded Surrozen from a "neutral" rating to an "underweight" rating in a report on Tuesday, November 29th. Finally, Guggenheim downgraded Surrozen from a "buy" rating to a "neutral" rating in a report on Friday, November 18th.
几位股票分析师最近发布了有关SRZN股票的报告。美国银行在11月16日星期三的一份研究报告中将Surrozen的股票从 “中性” 评级下调至 “表现不佳”。摩根大通在11月29日星期二的一份报告中将Surorzen的评级从 “中性” 下调至 “权重不足”。最后，古根海姆在11月18日星期五的一份报告中将Surorzen的评级从 “买入” 下调至 “中性”。
Surrozen Company Profile
Surrozen 公司简介
(Get Rating)
（获取评分）
Surrozen, Inc, a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.
Surrozen, Inc是一家生物技术公司，它发现并开发了候选药物，用于选择性地调节组织修复和再生的Wnt途径。它正在开发组织特异性抗体，应用于各种疾病领域，包括肠道、肝脏、视网膜、角膜、肺部、肾脏、耳蜗疾病、皮肤、胰腺和中枢神经系统疾病。
Featured Stories
精选故事
- Get a free copy of the StockNews.com research report on Surrozen (SRZN)
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
- Does it Matter Folks Aren't "Starry-Eyed" Over Pepsi's New Soda?
- Can Alaska Air Continue Soaring Above The Airline Industry?
- Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
- 免费获取 StockNews.com 关于 Surrozen (SRZN) 的研究报告的副本
- J.B. Hunt 持平，物流公司成为人们关注的焦点
- 英特尔股票即将爆发吗？
- 人们不对百事可乐的新苏打水 “满眼相看” 有关系吗？
- 阿拉斯加航空能否继续飞越航空业？
- 强生突围失败：收益能否提振股票？
Receive News & Ratings for Surrozen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surrozen and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Surrozen Daily 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Surrozen及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧